CymaBay Therapeutics, Inc. — Form D

CymaBay Therapeutics, Inc. of NEWARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-14. The offering totals $325K, of which $325K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Carl G Goldfischer, M.D.DirectorNewark, CA
Hari G Kumar, Ph.D.DirectorNewark, CA
Louis G Lange, M.D., Ph.D.DirectorNewark, CA
Harold Van Wart, Ph. D.DirectorNewark, CA
Kurt G von EmsterDirectorNewark, CA
Robert J WillsDirectorNewark, CA
Pol J BoudesExecutive OfficerNewark, CA
Charles A McWherter, Ph. D.Executive OfficerNewark, CA
Sujal A ShahExecutive OfficerNewark, CA
Harold Van Wart, Ph. D.Executive OfficerNewark, CA
Kurt von EmsterDirectorRedwood City, CA
Donald HillExecutive OfficerCoral Gables, FL
Paul QuinlanExecutive OfficerNew York, NY
Robert ZerbeDirectorGrand Rapids, MI
Bradley BolzonDirectorSAN DIEGO, CA
Louis LangeDirectorPalo Alto, CA
Anthony EvninDirectorCambridge, MA
Carl GoldfischerDirectorSan Diego, CA
Edward E Penhoet, Ph.D.DirectorHayward, CA
Edward PenhoetDirectorSeattle, WA
Daan van den NoortDirectorHaarlem, P7
David KarpfExecutive OfficerHayward, CA
Harold Van WartDirectorHayward, CA
Harold Van WartExecutive OfficerHayward, CA
Charles McWherterExecutive OfficerHayward, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2013-11-01D/A$45.0M$30.2M
2013-10-11D$45.0M$26.8M
2009-11-10D$8.6M$5.6M
2009-07-21D/A$27.7M$27.7M

More